🚀 Exciting News! Our Product Nilotinib Achieves DMF Listing with the FDA! 🚀

We' re thrilled to announce that our product Nilotinib has been successfully assigned a DMF number by the U.S. FDA! 

Nilotinib is a type of targeted cancer drug. It is a treatment for chronic myeloid leukaemia (CML).With this achievement, we continue to support better treatment outcomes for CML patients worldwide and provide high-quality API and service.

Welcome to consult !